Código QR (código de barras bidimensional)

A case report on the effective and safe use of ravulizumab in atypical hemolytic uremic syndrome during pregnancy

Abstract Background Atypical hemolytic uremic Syndrome (aHUS), a form of thrombotic microangiopathy (TMA), had a poor prognosis until the development of complement C5-inhibiting monoclonal antibodies, eculizumab and ravulizumab. While ravulizumab has shown effectiveness in treating postpartum TMA, d...

ver descrição completa

Na minha lista:
Principais autores: Abdulaziz Alkhaldi, Mamoun Elawad, Sultan Al Dalbhi, Bandar Alquraini, Alanoud Alshannan
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2026-04-01
coleção:BMC Nephrology
Assuntos:
Atypical hemolytic uremic syndrome
Case report
Eculizumab
Pregnancy
Ravulizumab
Acesso em linha:https://doi.org/10.1186/s12882-026-04950-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados